It wasn’t too long ago that SKU rationalization became commonplace, as many retailers attempted a course correction toward more profitable sets — establishing performance metrics that possibly favored bigger brands and their store-brand equivalents over slower-moving and slower-building brands. In other words, niche products. But now retailers are acknowledging they may have cut too much, opening a pathway of opportunity for many suppliers, especially those of promising niche brands. And, as the industry juggles the impact of a weak economy, ongoing consolidation and SKU rationalization, there’s no doubt that the role of the broker, or sales and marketing consultant, is changing and growing increasingly vital to niche brands and even retailers. Click below to download the PDF of Top 500.
The need to bridge the gap between the pharmacy counter and the rest of the retail operation is generating more discussion across the industry at a time of changing consumer attitudes and growing competition from a wider range of retailers — both brick-and-mortar and virtual. Read more
Chronic care management has become an all-consuming topic for retail pharmacy. It has moved beyond a niche industry topic to a high-profile, national conversation that involves healthcare costs, government policy, emerging technologies and, most importantly, daily life for millions of consumers. Read more
The DSN PoweRx list represents nearly 80% of the total retail pharmacy business — including more than $250 billion in pharmacy sales and nearly 59,000 pharmacies. And with the rise of more consumer-centered health care, they are creating innovative programs and entering healthcare partnerships to move beyond dispensing and expand their role in the U.S. healthcare delivery system. Read more
Industry leaders talk soulful brands, doing good and operating with purpose at the third annual New General Market Summit. In this special report, DSN highlights the big ideas and best practices that emerged from the event.